Legislation creating the Innovative Health Initiative (IHI) enters into force

‘Launching a new public-private partnership is a huge endeavour and we will work hard in the coming months to set up our new governance structures and launch our first Call for proposals as rapidly as possible,’ said IHI Executive Director Pierre Meulien.

Innovative Health Initiative Governing Board members named

The eight members of the Governing Board represent the Innovative Health Initiative public and private partners. The chair of the newly-created board is Irene Norstedt of the European Commission, and Salah-Dine Chibout of Novartis and EFPIA takes the role of deputy chair.

Save the date! IHI launch event on 26 January

What is the Innovative Health Initiative? Who are the partners? And how can I get involved? All your questions will be answered in the online IHI launch event on the morning of 26 January 2022.

From IMI to IHI...

Why are we changing, what's new, and what's staying the same? And what will happen to the Innovative Medicines Initiative (IMI) projects? Find out in our simple guide...

Computational modelling shows promise for predicting mortality risk after knee surgery

Some people are at higher risk than others of dying after the common procedure. IMI project EHDEN's modelling was able to identify them.

BEAMER aims to boost adherence to treatment

Around half of all patient’s don’t take their treatment as prescribed. New IMI project BEAMER wants to find out why and develop guidance to address this.

With multiple flu vaccines on offer, how do doctors choose?

IMI project DRIVE found fewer options for older people, and that younger people’s other risk factors play a part in the choice. This data is helping calculate the effectiveness of vaccination campaigns.

IMI project PROMISE puts spotlight on common respiratory infection

The new project focuses on respiratory syncytial virus (RSV), an infectious disease that can cause severe illness in young children and other vulnerable groups.

IMI-funded EPND platform set to accelerate research into neurodegenerative diseases

The new IMI project European Platform for Neurodegenerative Diseases (EPND) will set up a collaborative platform that will link up existing sample and data infrastructures.

Blood biomarker identified that predicts type 2 diabetes many years before diagnosis

A large study, part-funded by IMI through the DIRECT, SUMMIT and BEAT-DKD projects, identified a protein in the blood that could predict type 2 diabetes up to 19 years before the onset of disease.